Description

BPS Bioscience has developed a diverse portfolio of lentivirus products to study COVID-19, cell signaling pathways, CAR T-cell therapy, CRISPR, and immunotherapy. In addition to our product portfolio, we also offer custom services to develop a lentivirus suited for your research needs.

Customizable Options:

• Reporters (GFP, Luciferase, Dual Reporter)
• Antibiotic selection markers (Puromycin, Hygromycin, G418)
• Integrating or non integrating
• Pseudotyped
• CRISPR lentiviruses
• CRISPR activation lentiviruses

Item	Custom Lentivirus Services
Company	BPS Bioscience, Inc.
Price	Supplier PageView Company Product Page
Catalog Number	Custom